(EMN) Eastman Chemical - Overview
Stock: Additives, Advanced Materials, Chemical Intermediates, Fibers, Polymers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.58% |
| Yield on Cost 5y | 3.97% |
| Yield CAGR 5y | 4.15% |
| Payout Consistency | 98.3% |
| Payout Ratio | 45.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.7% |
| Relative Tail Risk | -9.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.48 |
| Alpha | -41.14 |
| Character TTM | |
|---|---|
| Beta | 1.249 |
| Beta Downside | 1.279 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.40% |
| CAGR/Max DD | -0.10 |
Description: EMN Eastman Chemical January 07, 2026
Eastman Chemical Company (NYSE: EMN) is a diversified specialty materials producer with operations in the United States, China, and other global markets. Its business is organized into four segments: Additives & Functional Products, Advanced Materials, Chemical Intermediates, and Fibers, each supplying a broad array of chemicals, polymers, and engineered fibers to end-markets such as transportation, construction, electronics, agriculture, and personal-care.
In FY 2023 Eastman generated roughly $13.5 billion in revenue and delivered an adjusted EBITDA margin near 12 %, reflecting strong pricing power in specialty niches despite volatile petrochemical feedstock costs. The company’s growth is tied to macro-drivers like the global shift toward higher-performance, low-VOC coatings, increasing demand for bio-based polymers, and sustained investment in infrastructure that fuels construction-related chemical consumption.
Key sector trends that could influence EMN’s outlook include tightening regulations on phthalate plasticizers, accelerating adoption of sustainable biopolymers, and cyclical pressure from ethylene and propylene price swings. Monitoring these variables alongside Eastman’s capital-expenditure plans for capacity expansion in its Advanced Materials line will be critical for assessing upside potential.
For a deeper dive into EMN’s valuation metrics and peer comparison, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 474.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.69 > 1.0 |
| NWC/Revenue: 18.64% < 20% (prev 14.85%; Δ 3.79% < -1%) |
| CFO/TA 0.06 > 3% & CFO 970.0m > Net Income 474.0m |
| Net Debt (5.08b) to EBITDA (1.30b): 3.91 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.9m) vs 12m ago -2.54% < -2% |
| Gross Margin: 21.07% > 18% (prev 0.24%; Δ 2083 % > 0.5%) |
| Asset Turnover: 57.98% > 50% (prev 61.67%; Δ -3.70% > 0%) |
| Interest Coverage Ratio: 3.62 > 6 (EBITDA TTM 1.30b / Interest Expense TTM 217.0m) |
Altman Z'' 3.26
| A: 0.11 (Total Current Assets 3.79b - Total Current Liabilities 2.16b) / Total Assets 14.98b |
| B: 0.67 (Retained Earnings 10.10b / Total Assets 14.98b) |
| C: 0.05 (EBIT TTM 785.0m / Avg Total Assets 15.10b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 9.14b) |
| Altman-Z'' Score: 3.26 = A |
What is the price of EMN shares?
Over the past week, the price has changed by +0.89%, over one month by +7.76%, over three months by +17.59% and over the past year by -21.74%.
Is EMN a buy, sell or hold?
- StrongBuy: 10
- Buy: 3
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EMN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.5 | 6% |
| Analysts Target Price | 73.5 | 6% |
| ValueRay Target Price | 74.8 | 7.9% |
EMN Fundamental Data Overview February 01, 2026
P/E Forward = 11.3766
P/S = 0.8763
P/B = 1.3702
P/EG = 4.2158
Revenue TTM = 8.75b USD
EBIT TTM = 785.0m USD
EBITDA TTM = 1.30b USD
Long Term Debt = 4.79b USD (from longTermDebt, two quarters ago)
Short Term Debt = 290.0m USD (from shortTermDebt, two quarters ago)
Debt = 5.08b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 5.08b USD (using Total Debt 5.08b, CCE unavailable)
Enterprise Value = 12.98b USD (7.91b + Debt 5.08b - (null CCE))
Interest Coverage Ratio = 3.62 (Ebit TTM 785.0m / Interest Expense TTM 217.0m)
EV/FCF = 30.62x (Enterprise Value 12.98b / FCF TTM 424.0m)
FCF Yield = 3.27% (FCF TTM 424.0m / Enterprise Value 12.98b)
FCF Margin = 4.84% (FCF TTM 424.0m / Revenue TTM 8.75b)
Net Margin = 5.42% (Net Income TTM 474.0m / Revenue TTM 8.75b)
Gross Margin = 21.07% ((Revenue TTM 8.75b - Cost of Revenue TTM 6.91b) / Revenue TTM)
Gross Margin QoQ = 17.13% (prev 19.66%)
Tobins Q-Ratio = 0.87 (Enterprise Value 12.98b / Total Assets 14.98b)
Interest Expense / Debt = 1.02% (Interest Expense 52.0m / Debt 5.08b)
Taxrate = 16.37% (93.0m / 568.0m)
NOPAT = 656.5m (EBIT 785.0m * (1 - 16.37%))
Current Ratio = 1.76 (Total Current Assets 3.79b / Total Current Liabilities 2.16b)
Debt / Equity = 0.88 (Debt 5.08b / totalStockholderEquity, two quarters ago 5.77b)
Debt / EBITDA = 3.91 (Net Debt 5.08b / EBITDA 1.30b)
Debt / FCF = 11.97 (Net Debt 5.08b / FCF TTM 424.0m)
Total Stockholder Equity = 5.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 474.0m / Total Assets 14.98b)
RoE = 8.15% (Net Income TTM 474.0m / Total Stockholder Equity 5.81b)
RoCE = 7.41% (EBIT 785.0m / Capital Employed (Equity 5.81b + L.T.Debt 4.79b))
RoIC = 6.02% (NOPAT 656.5m / Invested Capital 10.90b)
WACC = 6.74% (E(7.91b)/V(12.98b) * Re(10.52%) + D(5.08b)/V(12.98b) * Rd(1.02%) * (1-Tc(0.16)))
Discount Rate = 10.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.61%
[DCF Debug] Terminal Value 84.10% ; FCFF base≈529.6m ; Y1≈587.9m ; Y5≈767.2m
Fair Price DCF = 110.1 (EV 17.63b - Net Debt 5.08b = Equity 12.56b / Shares 114.1m; r=6.74% [WACC]; 5y FCF grow 12.71% → 2.90% )
EPS Correlation: -39.81 | EPS CAGR: -23.62% | SUE: 0.21 | # QB: 0
Revenue Correlation: -79.37 | Revenue CAGR: -8.11% | SUE: -0.79 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.22 | Chg30d=-0.030 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=6.02 | Chg30d=-0.104 | Revisions Net=-8 | Growth EPS=+11.0% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=6.95 | Chg30d=-0.121 | Revisions Net=-4 | Growth EPS=+15.5% | Growth Revenue=+2.7%